Topicals may not be enough
- Patients with dermatologic conditions will try multiple topicals, sometimes over the course of several years, hoping to find one that works for them5*
- Nearly 80% of patients would consider discontinuing topical treatment if they didn’t see any improvement in their symptoms after 2 weeks6†
- Most patients find the frequent and potentially messy topical application to be a burden1,3,6,7
– Patients’ challenges with topicals may include: greasy feeling, stickiness, unpleasant smell, stained clothes, slow absorption, stinging or burning sensation1,3,6,7
Biologics may feel like a step too far
Biologics may feel like a step too far
- Transitioning from a topical to an injectable can seem like a big step1,2,4
- For some patients, transitioning to biologics raises new concerns1,2,4
– Despite their doctors’ recommendations, nearly 1 in 3 patients has refused biologic treatment for reasons such as mode of administration and injection site reactions2‡
Patients hope for more
- Fewer than half of patients have seen any symptom improvement with their current treatment, with many patients reporting no difference in their conditions2‡
- 84% of patients see the need for better options to manage their skin conditions1§
When topical treatment alone has run its course, patients are left searching for something
JUST RIGHT1,3
JUST RIGHT1,3
References: 1. Lebwohl M, Langley RG, Paul C, et al. Dermatol Ther (Heidelb). 2022;12(1):61-78. doi:10.1007/s13555-021-00635-4 2. Armstrong AW, Bohannan B, Mburu S, et al. Dermatology. 2023;239(4):621-634.doi:10.1159/000528945 3. Wollenberg A, Gooderham M, Katoh N, et al. Arch Dermatol Res. 2024;316(7):380. doi:10.1007/s00403-024-03130-w 4. Wan V, Habibi A, Abdi P, Mukovozov I, Asiniwasis RN, Maibach HI. Australas J Dermatol. 2024;65(4):387-389. doi:10.1111/ajd.14243 5. Gupta S, Garbarini S, Nazareth T, Khilfeh I, Costantino H, Kaplan D. Dermatol Ther (Heidelb). 2021;11(6):2057-2075. doi:10.1007/s13555-021-00620-x 6. Curcio A, Kontzias C, Gorodokin B, Feldman S, Kircik L. J Drugs Dermatol. 2023;22(4):326-332. doi:10.36849/JDD.7372 7. Oliveira R, Almeida IF. Patient-centric design of topical dermatological medicines. Pharmaceuticals (Basel). 2023;16(4):617. doi:10.3390ph16040617